Drug therapy in autism.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of the American Academy of Child and Adolescent Psychiatry

• Publication date

  1997-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00004583-199705000-00004PMID 9136488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case Reports

  1995cited by this paper
• Autistic Disorder and Other Pervasive Developmental Disorders

  1995cited by this paper

• The Use of Risperidone in Adults with Asperger Syndrome

  2004cites this paper
• Use of Atypical Antipsychotics in Autism

  2003cites this paper
• Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.

  2002cites this paper
• Does risperidone have a place in the treatment of nonschizophrenic patients?

  2001influential citation
• Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

  2000cites this paper
• Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

  1999cites this paper
• A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

  1998cites this paper